Jay joined the group in 2009, initially studying for a PhD co-supervised with Prof. Andrew Owen in the Department of Pharmacology and Therapeutics. Since completing his PhD Jay has worked on numerous projects focused on the development of material chemistry approaches to overcome current limitations in poorly water-soluble drug therapies, with a particular focus on antiretrovirals. Having previously worked on large multinational and multidisciplinary research projects, Jay obtained extensive experience in a range of scientific disciplines including Materials Chemistry, Pharmacology, and Immunology, as well as engaging with diverse stakeholders across academic and industrial settings. These projects have produced numerous publications and patent filings in the field of nanomedicine. In January 2022 Jay became the Research Co-ordinator for the Bioactive Materials programmes within the wider Rannard research group, with a particular focus on long-acting therapeutics. Jay is based in the William Henry Duncan building and is a member of the Centre of Excellence for Long-acting Therapeutics (CELT).

 

CELT is a cross-faculty research initiative combining world leading expertise in pharmacology and materials chemistry and working with international partners to disseminate research findings in long-acting medicine and change the global landscape of drug administration.